265 related articles for article (PubMed ID: 34278005)
1. Combined analysis of whole blood interferon gamma release assay and complete blood count analysis for rapid discrimination of active tuberculosis and latent tuberculosis infection.
Kang YJ; Park H; Park SB; Kim J; Lee J; Kim J; Park S; Lee YS; Kim S
J Clin Tuberc Other Mycobact Dis; 2021 Aug; 24():100253. PubMed ID: 34278005
[TBL] [Abstract][Full Text] [Related]
2. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
Harada N
Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
[TBL] [Abstract][Full Text] [Related]
4. High Procalcitonin, C-Reactive Protein, and α-1 Acid Glycoprotein Levels in Whole Blood Samples Could Help Rapid Discrimination of Active Tuberculosis from Latent Tuberculosis Infection and Healthy Individuals.
Kang YJ; Park H; Park SB; Lee J; Hyun H; Jung M; Lee EJ; Je MA; Kim J; Lee YS; Kim S
Microorganisms; 2022 Sep; 10(10):. PubMed ID: 36296203
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of Tuberculin Skin Test (TST) and T-SPOT.TB Tests for Diagnosis of Latent Tuberculosis Infection (LTBI) in HIV-infected Patients].
Binay UD; Fincancı M; Fersan E; Karakeçili F
Mikrobiyol Bul; 2019 Oct; 53(4):388-400. PubMed ID: 31709936
[TBL] [Abstract][Full Text] [Related]
6. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
[TBL] [Abstract][Full Text] [Related]
7. The meta-analysis for ideal cytokines to distinguish the latent and active TB infection.
Wei Z; Li Y; Wei C; Li Y; Xu H; Wu Y; Jia Y; Guo R; Jia J; Qi X; Li Z; Gao X
BMC Pulm Med; 2020 Sep; 20(1):248. PubMed ID: 32948170
[TBL] [Abstract][Full Text] [Related]
8. Potential Immunological Biomarkers for Detection of Mycobacterium tuberculosis Infection in a Setting Where M. tuberculosis Is Endemic, Ethiopia.
Teklu T; Kwon K; Wondale B; HaileMariam M; Zewude A; Medhin G; Legesse M; Pieper R; Ameni G
Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311240
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of interferon-γ release assay for the diagnosis of latent tuberculosis infection in young children.
Yun KW; Kim YK; Kim HR; Lee MK; Lim IS
Korean J Pediatr; 2016 Jun; 59(6):256-61. PubMed ID: 27462354
[TBL] [Abstract][Full Text] [Related]
10. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
Sato S; Nagai H
Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
[TBL] [Abstract][Full Text] [Related]
11. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
[TBL] [Abstract][Full Text] [Related]
12. HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study.
Pullar ND; Steinum H; Bruun JN; Dyrhol-Riise AM
BMC Infect Dis; 2014 Dec; 14():667. PubMed ID: 25515915
[TBL] [Abstract][Full Text] [Related]
13. Improving T-cell assays for diagnosis of latent TB infection: Confirmation of the potential role of testing Interleukin-2 release in Iranian patients.
Mamishi S; Pourakbari B; Shams H; Marjani M; Mahmoudi S
Allergol Immunopathol (Madr); 2016; 44(4):314-21. PubMed ID: 26786720
[TBL] [Abstract][Full Text] [Related]
14. The diagnosis of latent tuberculosis infection (LTBI): currently available tests, future developments, and perspectives to eliminate tuberculosis (TB).
Zellweger JP; Sotgiu G; Corradi M; Durando P
Med Lav; 2020 Jun; 111(3):170-183. PubMed ID: 32624559
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis for Latent Tuberculosis Infection: New Alternatives.
Carranza C; Pedraza-Sanchez S; de Oyarzabal-Mendez E; Torres M
Front Immunol; 2020; 11():2006. PubMed ID: 33013856
[TBL] [Abstract][Full Text] [Related]
16. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
[TBL] [Abstract][Full Text] [Related]
17. The Biological and Clinical Aspects of a Latent Tuberculosis Infection.
Khabibullina NF; Kutuzova DM; Burmistrova IA; Lyadova IV
Trop Med Infect Dis; 2022 Mar; 7(3):. PubMed ID: 35324595
[TBL] [Abstract][Full Text] [Related]
18. Relationship between DNA Methylation Profiles and Active Tuberculosis Development from Latent Infection: a Pilot Study in Nested Case-Control Design.
Du Y; Gao X; Yan J; Zhang H; Cao X; Feng B; He Y; He Y; Guo T; Xin H; Gao L
Microbiol Spectr; 2022 Jun; 10(3):e0058622. PubMed ID: 35446152
[TBL] [Abstract][Full Text] [Related]
19. Advancing new diagnostic tests for latent tuberculosis infection due to multidrug-resistant strains of Mycobacterium tuberculosis - End of the road?
Mwaba P; Chakaya JM; Petersen E; Wejse C; Zumla A; Kapata N
Int J Infect Dis; 2020 Mar; 92S():S69-S71. PubMed ID: 32119979
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]